<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.2" -->
<rss version="0.92">
<channel>
	<title>DWS Pill Scribe</title>
	<link>http://www.dancewithshadows.com/pillscribe</link>
	<description>The best of pharma news and views</description>
	<lastBuildDate>Fri, 19 Mar 2010 19:52:30 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Teva buys out Ratiopharm for €3.63 bn; climbs on to list of top-notch drug firms</title>
		<description><![CDATA[Israeli drug manufacturer Teva Pharmaceutical Industries Ltd will acquire Ratiopharm Group International for €3.63 billion &#8211; $4.97 billion in dollar terms – to hop on to one of the top most slots in Europe’s generic drug scenario.

By all counts, the new acquisition would be rated as the largest takeover in the generic drug market since [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/teva-buys-out-ratiopharm-for-e3-63-bn-climbs-on-to-list-of-top-notch-drug-firms/</link>
			</item>
	<item>
		<title>Methylnaltrexone (Relistor) pills to treat constipation to go on crucial phase of clinical studies, says Progenics</title>
		<description><![CDATA[Methylnaltrexone, an oral tablet for opioid-induced constipation (OIC) by Progenics, will soon undergo late stage clinical studies.

Progenics Pharmaceuticals, Inc plans to commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010, the company said in a press release.
The study of the methylnaltrexone tablet was conducted in [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/methylnaltrexone-relistor-pills-to-treat-constipation-to-go-on-crucial-phase-of-clinical-studies-says-progenics/</link>
			</item>
	<item>
		<title>Bayer looks to double workforce in India; targets to be among top 10 by 2015</title>
		<description><![CDATA[Bayer Schering Pharma AG, Germany&#8217;s largest pharmaceutical company is planning to double its sales force in India as part of its strategy to make Asia an important market through making huge investments in the region, reports said.

Over 20% of Bayer&#8217;s healthcare division&#8217;s 2009 sales were generated from the Asia Pacific region.
Bayer Schering Pharma is currently [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/bayer-looks-to-double-workforce-in-india-targets-to-be-among-top-10-by-2015/</link>
			</item>
	<item>
		<title>Oral contraceptive pills could help women live longer; cut heart disease, cancer risks: Study</title>
		<description><![CDATA[Contraceptive pills used by women for birth-control could help them lead a longer life with lesser risk of major life-threatening conditions like heart disease and cancer, says a new study.

The study conducted in more than 46,000 women over a period of 40 years showed that contraceptive pills users were less likely to die of heart [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/oral-contraceptive-pills-could-help-women-live-longer-cut-heart-disease-cancer-risks-study/</link>
			</item>
	<item>
		<title>Stem cell-based vaccine against brain cancer improves survival:ImmunoCellular</title>
		<description><![CDATA[A dendritic cell-based vaccination with cancer stem cells developed by ImmunoCellular has been found improving the survival rate of brain cancer -glioblastoma &#8211; patients.

ImmunoCellular&#8217;s experimental cancer stem cells vaccine demonstrated a statistically significant&#8221; survival benefit in a preclinical animal model of glioblastoma, the company announced in a press statement
In the preclinical studies, the rats were [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/stem-cell-based-vaccine-against-brain-cancer-improves-survivalimmunocellular/</link>
			</item>
	<item>
		<title>Bayer&#8217;s cipro inhaler to treat cystic fibrosis may get priority review in US</title>
		<description><![CDATA[Ciprofloxacin dry powder inhaler to treat cystic fibrosis caused by Pseudomonas aeruginosa has been given Orphan Drug designation in US, announced Bayer Healthcare.

Ciprofloxacin dry powder inhaler is an investigational drug–device combination that combines ciprofloxacin dry powder formulated using Novartis&#8217; proprietary PulmoSphere technology with a delivery inhaler.
First-in-man studies with ciprofloxacin dry powder inhaler in cystic fibrisis [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/bayers-cipro-inhaler-to-treat-cystic-fibrosis-may-get-priority-review-in-us/</link>
			</item>
	<item>
		<title>Indian herbal drug Ayusrem can treat H1N1 swine flu: Researchers</title>
		<description><![CDATA[Ayusrem, a herbal drug to treat H1N1 swine flu developed by two Indian scientists from Chennai, has been lauched for sales.

Ayusrem, prepared using the traditional approach of Indian classical medicine system Ayurveda has been found safe and effective, the researchers claimed.
The medicine contains 32 different herbal components.
Ayusrem preparation can prevent the spread of  a host [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/indian-herbal-drug-ayusrem-can-treat-h1n1-swine-flu-researchers/</link>
			</item>
	<item>
		<title>Intravenous macrolide antibiotic CEM-101 to go on clinical studies soon: Cempra</title>
		<description><![CDATA[CEM-101, an oral new generation macrolide antibiotic developed by Cempra Pharmaceuticals, will soon go on clinical studies to establish the drug&#8217;s efficacy as as intravenous formulation.

CEM-101 is a next-generation macrolide with potent activity against pneumococci, including macrolide- and quinolone-resistant strains. Bacterial pneumonia caused by multi-drug resistant pneumococci can result in clinical treatment failure and subsequent [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/intravenous-macrolide-antibiotic-cem-101-to-go-on-clinical-studies-soon-cempra/</link>
			</item>
	<item>
		<title>Scivanta Cardiac Monitoring System measures heart performance more accurately:  Scivanta Medical</title>
		<description><![CDATA[Scivanta Cardiac Monitoring System (SCMS) can accurately measure cardiac performance, according to Scivanta Medical Corporation.

Clinical studies performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, New York have established that Scivanta Cardiac Monitoring System is safe as well, Scivanta Medical said in a press release.
The clinical trial was designed to obtain data concerning the safety and [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/scivanta-cardiac-monitoring-system-measures-heart-performance-more-accurately-scivanta-medical/</link>
			</item>
	<item>
		<title>Fentanyl spray could relieve breakthrough cancer pain in five minutes: Insys</title>
		<description><![CDATA[Fentanyl sublingual spray developed by Insys Therapeutics to treat breakthrough cancer pain has been found effective in clinical studies.

Insys Therapeutics has announced positive results from the pivotal phase III efficacy trial. All primary and secondary endpoints were achieved in the study.
Fentanyl sublingual spray is the first product to ever show statistically significant pain relief when [...]]]></description>
		<link>http://www.dancewithshadows.com/pillscribe/fentanyl-spray-could-relieve-breakthrough-cancer-pain-in-five-minutes-insys/</link>
			</item>
</channel>
</rss>
